Clinical Trials Logo

Clinical Trial Summary

The study is designed to assess the safety and immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI GSD 205, as a booster vaccination.


Clinical Trial Description

Study Objectives: Primary: To assess safety of Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI GSD 205, as a booster vaccination as a single dose or a three-dose series, and To assess immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI GSD 205, as a booster vaccination as a single dose or a three-dose series Secondary: To assess incidence of VEE infection in C-84 boosted personnel. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00582088
Study type Interventional
Source U.S. Army Medical Research and Development Command
Contact
Status Active, not recruiting
Phase Phase 2
Start date March 2008
Completion date December 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00582504 - Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine Phase 2
Not yet recruiting NCT03531242 - Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults Phase 2